DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Ecological Momentary Assessment of Eating Behavior in Overweight Youth

Completed

Conditions: Obesity

First Posted Date: 2015-10-23

Last Posted Date: 2024-05-07

Lead Sponsor: University of Chicago

Target Recruit Count: 44

Registration Number: NCT02585518

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Phase 1

Withdrawn

Conditions: Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer

Interventions: Biological: Cetuximab
Drug: Fluorouracil
Drug: Irinotecan Hydrochloride
Drug: Leucovorin Calcium

First Posted Date: 2015-10-09

Last Posted Date: 2016-12-09

Lead Sponsor: University of Chicago

Registration Number: NCT02573220

Locations: 🇮🇹
Centro di Riferimento Oncologico, Aviano, Italy

Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Cytarabine
Drug: Mitoxantrone Hydrochloride
Drug: Selinexor

First Posted Date: 2015-10-09

Last Posted Date: 2020-04-08

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT02573363

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

A Study to Determine if Caffeine Accelerates Emergence From Anesthesia

Phase 4

Completed

Conditions: Anesthesia

Interventions: Drug: Placebo Control
Drug: Caffeine

First Posted Date: 2015-10-05

Last Posted Date: 2018-08-16

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT02567968

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Electrical Nerve Stimulation of the Ulnar Nerve

Not Applicable

Withdrawn

Conditions: Cubital Tunnel Syndrome

Interventions: Device: Ulnar Nerve Stimulation

First Posted Date: 2015-10-02

Last Posted Date: 2017-04-05

Lead Sponsor: University of Chicago

Registration Number: NCT02566616

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Sleep Apnea Video Education for CPAP (SAVE-CPAP)

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Other: Usual education
Other: Enhanced education
Other: Usual follow up
Other: Enhanced follow up

First Posted Date: 2015-09-17

Last Posted Date: 2017-03-03

Lead Sponsor: University of Chicago

Target Recruit Count: 212

Registration Number: NCT02553694

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Device: Deep Brain Stimulation (DBS) at 60 Hz
Device: Deep Brain Stimulation (DBS) at 130 Hz
Device: Deep Brain Stimulation (DBS) Off (Sham)

First Posted Date: 2015-09-15

Last Posted Date: 2020-10-29

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT02549859

Locations: 🇺🇸
University of Chicago, Department of Neurology, Chicago, Illinois, United States

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Not Applicable

Terminated

Conditions: Metastatic Renal Cell Cancer
Recurrent Renal Cell Carcinoma
Stage IV Renal Cell Cancer

Interventions: Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2015-09-04

Last Posted Date: 2024-05-30

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT02542202

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Phase 1

Completed

Conditions: Unresectable Malignant Neoplasm
Solid Neoplasm
Metastatic Malignant Neoplasm

Interventions: Drug: Ilorasertib
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-09-04

Last Posted Date: 2019-04-22

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT02540876

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Vortioxetine for Binge Eating Disorder

Phase 2

Completed

Conditions: Binge Eating Disorder

Interventions: Drug: Placebo
Drug: Vortioxetine

First Posted Date: 2015-08-19

Last Posted Date: 2020-11-23

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT02528409

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy